Among AML cases, we found that the most common aberrant antigen was CD19, this is in contrast to the study conducted by Hamid A et al in which CD19 along with CD7 were found as common aberrant antigens in AML cases.19 This evidence concerns the gene CD19 and acute myeloid leukemia.